Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 29)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
8-Feb-10PriceTarget Research, Inc.N/AAspenbio Pharma has a current Overall Rating of D (Negative).7$25  View Abstract
6-Feb-10Standard & Poor's Quantitative ReportN/AAspenBio Pharma6$25  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: ASPENBIO PHARMA -- APPY1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: APPY , DARA , NEOL , PARS , SNT -- DRUGS3$4  View Abstract
4-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for AspenBio Pharma, Inc.41$65  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ASPENBIO PHARMA INC5$25  View Abstract
27-Jan-10Zacks Investment Research Inc.N/AASPENBIO PHARMA (APPY) Zacks Company Snapshot1$10  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ASPENBIO PHARMA INC5$25  View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ASPENBIO PHARMA INC5$25  View Abstract
13-Jan-10Life Science AnalyticsLife Science AnalyticsAspenBio Pharma Inc.-Company Report20$150  View Abstract
Next 19

Independent Reports (Showing 1 to 10 of 29)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
8-Feb-10PriceTarget Research, Inc.N/AAspenbio Pharma has a current Overall Rating of D (Negative).7$25View Abstract
6-Feb-10Standard & Poor's Quantitative ReportN/AAspenBio Pharma6$25View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: ASPENBIO PHARMA -- APPY1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: APPY , DARA , NEOL , PARS , SNT -- DRUGS3$4View Abstract
4-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for AspenBio Pharma, Inc.41$65View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ASPENBIO PHARMA INC5$25View Abstract
27-Jan-10Zacks Investment Research Inc.N/AASPENBIO PHARMA (APPY) Zacks Company Snapshot1$10View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ASPENBIO PHARMA INC5$25View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ASPENBIO PHARMA INC5$25View Abstract
13-Jan-10Life Science AnalyticsLife Science AnalyticsAspenBio Pharma Inc.-Company Report20$150View Abstract
Next 19

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.